WATSON 837 15 (Clorazepate 15 mg)
Pill with imprint WATSON 837 15 is Pink, U-shape and has been identified as Clorazepate dipotassium 15 mg. It is supplied by Watson Pharmaceuticals.
Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 15 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 837 15
Clorazepate dipotassium
- Imprint:
- WATSON 837 15
- Strength:
- 15 mg
- Color:
- Pink
- Shape:
- U-shape
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 52544-0837
More about clorazepate
- Clorazepate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 28 Reviews – Add your own review/rating
- Drug class: benzodiazepines
Consumer resources
Other brands: Tranxene, Tranxene T-Tab, Tranxene SD
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
